Literature DB >> 17216572

Co-located substance use treatment and HIV prevention and primary care services, New York State, 1990-2002: a model for effective service delivery to a high-risk population.

Jeffrey Rothman1, Diane Rudnick, Marc Slifer, Bruce Agins, Karl Heiner, Guthrie Birkhead.   

Abstract

The New York State Department of Health (NYSDOH) AIDS Institute (AI) began an initiative in 1990 in collaboration with the Office of Alcoholism and Substance Abuse Services (OASAS) to colocate HIV prevention and clinical services at drug treatment clinics. In 1990, the initiative began funding drug treatment programs to provide HIV counseling, testing, and prevention services. HIV primary care was added the following year. Program implementation and development are described. An analysis is included of HIV counseling and testing data for the period 1990-2002 and quality of care data for five standardized quality measures with comparisons to data from other clinical settings. In the first 13 years of the initiative 168,340 HIV-antibody tests were conducted including 52,562 tests of injection drug users (IDUs) identifying 14,612 HIV-infected persons; the seroprevalence was 8.68%. By the end of 2000, the HIV primary care caseload peaked at 3,815 patients. Quality of primary medical care services among participating drug treatment programs has consistently matched or exceeded that provided in more conventional health care settings such as the hospitals and community health centers that were used as a basis for comparison. Colocating HIV primary care within substance use treatment is an effective strategy for providing accessible high-quality HIV prevention and primary care services.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17216572      PMCID: PMC2231631          DOI: 10.1007/s11524-006-9137-3

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  6 in total

1.  Case management as a mechanism for linking drug abuse treatment and primary care: preliminary evidence from the ADAMHA/HRSA linkage demonstration.

Authors:  W E Schlenger; L A Kroutil; E J Roland
Journal:  NIDA Res Monogr       Date:  1992

2.  Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996.

Authors:  D C Des Jarlais; T Perlis; S R Friedman; S Deren; T Chapman; J L Sotheran; S Tortu; M Beardsley; D Paone; L V Torian; S T Beatrice; E DeBernardo; E Monterroso; M Marmor
Journal:  Am J Public Health       Date:  1998-12       Impact factor: 9.308

Review 3.  The impact of HIV infection on medical services in drug abuse treatment programs.

Authors:  P A Selwyn
Journal:  J Subst Abuse Treat       Date:  1996 Sep-Oct

4.  Providing medical care to methadone clinic patients: referral vs on-site care.

Authors:  A Umbricht-Schneiter; D H Ginn; K M Pabst; G E Bigelow
Journal:  Am J Public Health       Date:  1994-02       Impact factor: 9.308

5.  Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program.

Authors:  P A Selwyn; N S Budner; W C Wasserman; P S Arno
Journal:  Public Health Rep       Date:  1993 Jul-Aug       Impact factor: 2.792

6.  Satisfaction with ambulatory care of persons with AIDS: predictors of patient ratings of quality.

Authors:  V E Stone; J S Weissman; P D Cleary
Journal:  J Gen Intern Med       Date:  1995-05       Impact factor: 5.128

  6 in total
  21 in total

1.  Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs.

Authors:  Amanda J Abraham; Lauren A O'Brien; Hannah K Knudsen; Brian E Bride; G Rush Smith; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2012-04-25

2.  Factors associated with returning to HIV care after a gap in care in New York State.

Authors:  Chinazo O Cunningham; Johanna Buck; Fiona M Shaw; Laurence S Spiegel; Moonseong Heo; Bruce D Agins
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-01       Impact factor: 3.731

3.  Determinants of the availability of hepatitis C testing services in opioid treatment programs: results from a national study.

Authors:  Jemima A Frimpong; Thomas D'Aunno; Lan Jiang
Journal:  Am J Public Health       Date:  2014-04-17       Impact factor: 9.308

4.  HIV risk behaviors, perceived severity of drug use problems, and prior treatment experience in a sample of young heroin injectors in Dar es Salaam, Tanzania.

Authors:  John Atkinson; Sheryl McCurdy; Mark Williams; Jessie Mbwambo; Gad Kilonzo
Journal:  Afr J Drug Alcohol Stud       Date:  2011

5.  Tuberculosis screening in a novel substance abuse treatment center in Malaysia: implications for a comprehensive approach for integrated care.

Authors:  Haider Abdulrazzaq Abed Al-Darraji; Kee Cheong Wong; David Gan Eng Yeow; Jeannia Jiani Fu; Kelsey Loeliger; Christopher Paiji; Adeeba Kamarulzaman; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2013-09-24

6.  HIV/AIDS services in private substance abuse treatment programs.

Authors:  Amanda J Abraham; Lauren A O'Brien; Brian E Bride; Paul M Roman
Journal:  Drug Alcohol Depend       Date:  2010-12-08       Impact factor: 4.492

7.  Correlates of Self-Reported HIV Testing Among Patients in Specialized Substance Abuse Treatment Centers in South Africa.

Authors:  Beverley Cummings; Warren Lucas; Jacqueline Burgess; Siphokazi Dada; Charles D H Parry; Nadine Harker
Journal:  AIDS Behav       Date:  2021-05-05

8.  Evolution of child mental health services in primary care.

Authors:  Kelly J Kelleher; Jack Stevens
Journal:  Acad Pediatr       Date:  2009 Jan-Feb       Impact factor: 3.107

9.  Delivery of HIV Antiretroviral Therapy Adherence Support Services by HIV Care Providers in the United States, 2013 to 2014.

Authors:  John Weiser; Linda Beer; John T Brooks; Kathleen Irwin; Brady T West; Christopher C Duke; Garrett W Gremel; Jacek Skarbinski
Journal:  J Int Assoc Provid AIDS Care       Date:  2017-09-13

10.  Recent drug use, homelessness and increased short-term mortality in HIV-infected persons with alcohol problems.

Authors:  Alexander Y Walley; Debbie M Cheng; Howard Libman; David Nunes; C Robert Horsburgh; Richard Saitz; Jeffrey H Samet
Journal:  AIDS       Date:  2008-01-30       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.